Could a sleep drug help kids with autism rest better?

NCT ID NCT05546554

Recruiting now Symptom relief Sponsor: Stanford University Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether suvorexant (Belsomra) can improve sleep in teenagers with autism spectrum disorder. About 26 teens aged 13-17 will receive either the drug or a placebo in a crossover design over 8 weeks. Researchers will measure sleep quality using brain wave recordings and activity monitors.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: suvorexant (Belsomra)
What this could lead to: If it works, this could point toward a safe sleep aid for children and teens with autism who have trouble falling or staying asleep.
What could go wrong: This is a small, early-phase trial with only 26 participants, so results may not apply to everyone. Suvorexant can cause side effects like drowsiness or dizziness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AUTISM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

autism autism spectrum disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AUTISM AUTISM SPECTRUM DISORDER

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Stanford University
RECRUITING

Stanford, California, 94305-5719, United States

Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.